David M. Beauchamp

David Beauchamp practices at Lincoln - Donalson Care Center in Fayetteville, Tennessee.

David Beauchamp's NPI, 1316406499, was assigned on March 18, 2019. David Beauchamp holds Tennessee license 3833.

David Beauchamp's primary practice is Lincoln - Donalson Care Center, at 1681 Winchester Hwy, Fayetteville, TN 37334 in Lincoln County. The practice phone is (931) 438-4624.

David Beauchamp's primary practice is Lincoln - Donalson Care Center in Fayetteville, Tennessee. David Beauchamp is also affiliated with Covenant Health Parkwest. The medical group on file is TeamHealth. Dmand AI also links David Beauchamp to 4 more medical groups, 1 group practice or clinic, 1 rural health clinic and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where David Beauchamp practices, 4 sites in all. Vendor and product names are available with a free account.

Physician assistant is David Beauchamp's primary specialty in the NPI Registry, under taxonomy code 363A00000X. David Beauchamp is licensed in Tennessee.

CMS counts 371 Medicare patients who saw David Beauchamp in 2024. The largest group is 85 and over, with 141 patients. 75% of them have anxiety, and 75% have depression. 51% are also on Medicaid. Their average risk score is 2.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts David Beauchamp's median patient age at 78, with 56% women.

In 2024, David Beauchamp wrote 400 Medicare Part D claims for 59 patients. 99% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for David Beauchamp for performance year 2024, reported through an alternative payment model (APM). David Beauchamp accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists David Beauchamp as offering telehealth.

CMS Open Payments shows 1 general payment to David Beauchamp from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Neurocrine BioSciences, Inc. paid the most, $124.